Spyre Therapeutics, Inc.’s SYRE share price has surged by 6.55%, which has investors questioning if this is right time to ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

The company has a long presence in therapeutics for the disease, with drugs like TNF inhibitor Humira (adalimumab), now seeing sales in decline due to biosimilar competition, and has been adding ...

Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US. The importance of biosimilars only continues ...

As of 3:50:36 PM EDT. Market Open.

**NM signifies a non meaningful value. A dash signifies the data is not available.

As of 12:25:42 GMT-4. Market open.